Revolution Medicines, Inc. is 4.6x more valuable than Arcellx, Inc. by market capitalization ($30.74 B vs $6.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ACLX | RVMD |
|---|---|---|
| Market cap | $6.73 B | $30.74 B |
| US-listed rank | #1180 | #453 |
| Revenue (latest FY) | $22.29M | $0.00 |
| Net income (latest FY) | -$228.93M | -$1.13B |
| Net margin | -1027.3% | - |
| SEC filings | 448 | 782 |
Revolution Medicines, Inc. is 4.6x more valuable than Arcellx, Inc. by market capitalization ($30.74 B vs $6.73 B).
In their latest fiscal years, Arcellx, Inc. reported $22.29M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Arcellx, Inc. and Revolution Medicines, Inc., or browse the full rankings.